Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

Pauken, Kristen E., Sammons, Morgan A., Odorizzi, Pamela M., Manne, Sasikanth, Godec, Jernej, Khan, Omar, Drake, Adam M., Chen, Zeyu +11 more·2016·Science

DOI 10.1126/science.aaf2807

Cited by (1,000)

Items 701–800 of 1,000

Analysis of Immune Resistance Mechanisms in TNBC: Dual Effects Inside and Outside the Tumor
Jian Xu, Gan Chen, Sheng Yu, Senbang Yao, Wen Li, Huaidong Cheng · 2023 · Clinical Breast Cancer
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies
Sarra Mestiri, Ana Sami, Naresh Sah, Dina Moustafa Abo El-Ella, Sabiha Khatoon, Khadija Shafique, Afsheen Raza, Darin Mansor Mathkor, Shafiul Haque · 2025 · Cancer and Metastasis Reviews
T Cell Exhaustion: An Epigenetically Imprinted Phenotypic and Functional Makeover
Francesca Alfei, Dietmar Zehn · 2017 · Trends in Molecular Medicine
PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii
Samantha D. Splitt, Scott P. Souza, Kristen M. Valentine, Brayan E. Castellanos, Andrew B. Curd, Katrina K. Hoyer, Kirk D.C. Jensen · 2018 · Infection and Immunity
Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response
Isabella McGoverne, Jenny Dunn, Jacob Batham, Wen Juan Tu, Jeremy S. Chrisp, Sudha Rao · 2020 · BMC Immunology
Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8+ T cell exhaustion
Yanmin Cheng, Zhaozhao Shao, Li Chen, Qiaoyu Zheng, Qiqi Zhang, Wenjie Ding, Meng Zhang, Qiongfang Yu, Dian Gao · 2020 · Immunology Letters
Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells
Weber, Evan W., Lynn, Rachel C., Parker, Kevin R., Anbunathan, Hima, Lattin, John, Sotillo, Elena, Good, Zinaida, Malipatlolla, Meena, Xu, Peng, Vandris, Panos et al. · 2020
Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?
Sang Youn Hwang, Sangjune Laurence Lee, Hongqun Liu, Samuel S. Lee · 2023 · Liver Cancer
CD4+ T cell dysfunction in cancer
Hrishi Venkatesh, Lawrence H. Fong · 2025 · The Journal of Experimental Medicine
Risk of immune-related colitis with PD-1/PD-L1 inhibitors vs chemotherapy in solid tumors: systems assessment
Qiang Su, Xiaochen Zhang, Xinhua Shen, Yanli Hou, Zhi‐Gang Sun, Zu Hua Gao · 2018 · Journal of Cancer
Methio “mine”! Cancer cells steal methionine and impair CD8 T‐cell function
Patrick M. Gubser, Axel Kallies · 2020 · Immunology and Cell Biology
Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review
K.P. Mishra, Mrinalini Singh, Deepika Saraswat, Lilly Ganju, Rajeev Kumar Varshney · 2022 · Viral Immunology
Application of ATAC-seq in tumor-specific T cell exhaustion
Chufeng Chen, Jiaying Liu, Yidong Chen, Anqi Lin, Weiming Mou, Lingxuan Zhu, Tao Yang, Quan Cheng, Jian Zhang, Peng Luo · 2022 · Cancer Gene Therapy
Immune Checkpoint Molecules and Glucose Metabolism in HIV-Induced T Cell Exhaustion
Yee Teng Chan, Heng Choon Cheong, Ting Fang Tang, Reena Rajasuriar, Kian‐Kai Cheng, Chung Yeng Looi, Won Fen Wong, Adeeba Kamarulzaman · 2022 · Biomedicines
Metabolic Challenges in Anticancer CD8 T Cell Functions
Andrea M. Amitrano, Minsoo Kim · 2023 · Immune Network
Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints
Dharmindra Dulal, Andrew R. Boring, David Terrero, Tiffany L. Johnson, Amit Kumar Tiwari, Dayanidhi Raman · 2023 · Cancers
Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer
Kyunghee Burkitt · 2023 · Cancers
Selective control of transposable element expression during T cell exhaustion and anti–PD-1 treatment
Pierre‐Emmanuel Bonté, Christina Metoikidou, Sandrine Heurtebise-Chrétien, Yago A. Arribas, Aurélien Sutra Del Galy, Mengliang Ye, Leticia Laura Niborski, Elina Zueva, Eliane Piaggio, Agathe Seguin‐Givelet et al. · 2023 · Science Immunology
Intracellular K+ Limits T-cell Exhaustion and Preserves Antitumor Function
Camille Collier, Kelly Wucherer, Matthew McWhorter, Chelsea Jenkins, Alexandra Q. Bartlett, Rahul Roychoudhuri, Robert L Eil · 2023 · Cancer Immunology Research
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response
Courtney H. Coschi, Rosalyn Anne Juergens · 2023 · Current Oncology
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness
Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, Elena Ceccacci, Silvia Tiberti, Dorothee Haas, J. Samson, Christoph Heuser-Loy, Carina B. Nava Lauson, Marta Mangione et al. · 2024 · Nature Communications
Multilayer regulation of CD4 T cell subset differentiation in the era of single cell genomics
Waradon Sungnak, Chao Wang, Vijay Kumar Kuchroo · 2019 · Advances in immunology
PD-1 aborts the activation trajectory of autoreactive CD8+ T cells to prohibit their acquisition of effector functions
Hikari Okamura, Il‐mi Okazaki, Kenji Shimizu, Takumi Maruhashi, Daisuke Sugiura, Reina Mizuno, Taku Okazaki · 2019 · Journal of Autoimmunity
Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies
Chunyi Shen, Zhen Zhang, Yi Zhang · 2020 · BioMed Research International
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
Éléonore De Guillebon, Marta Jimenez, Luca Mazzarella, Fay Betsou, Peter Florian Stadler, István Peták, Emmanuelle Jeannot, Laëtitia Chanas, Nicolas Servant, Grégoire Marret et al. · 2021 · ESMO Open
The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors
Tiffany C. Blair, Alejandro F. Alice, Lauren Zebertavage, Marka R. Crittenden, Michael J. Gough · 2021 · Frontiers in Oncology
Clinical Perspectives to Overcome Acquired Resistance to Anti–Programmed Death-1 and Anti–Programmed Death Ligand-1 Therapy in Non-Small Cell Lung Cancer
Yong Jun Lee, Jii Bum Lee, Sang‐Jun Ha, Hye Ryun Kim · 2021 · Molecules and Cells
Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma
Thomas J. Lai, Lu Sun, Kevin Li, Terry J. Prins, Janet M. Treger, Tie Li, Matthew Z. Sun, David A. Nathanson, Linda M. Liau, Albert Lai et al. · 2024 · Cancer Research Communications
Degradation of IKZF1 prevents epigenetic progression of T cell exhaustion in an antigen-specific assay
Tristan Tay, Gayathri Bommakanti, Elizabeth S. Jaensch, Aparna Gorthi, Iswarya Karapa Reddy, Yan Hu, Ruochi Zhang, Aatman S. Doshi, Sin Lih Tan, Verena Brucklacher-Waldert et al. · 2024 · Cell Reports Medicine
Deciphering immune predictors of immunotherapy response: A multiomics approach at the pan-cancer level
Xuexin Li, Lu Pan, Weiyuan Li, Bingyang Liu, Chunjie Xiao, Valerie Chew, Xuan Zhang, Long Wang, Florent Ginhoux, Joseph Loscalzo et al. · 2025 · Cell Reports Medicine
Immunometabolite L-2-HG promotes epigenetic modification of exhausted T cells and improves antitumor immunity
Yanying Yang, Xiaoyan Li, Fangming Liu, Mingyue Ma, Ying Yang, Cheng‐Chao Ruan, Yan Lü, Xiaoyang Li, Xiangdong Wang, Ying–Hong Shi et al. · 2025 · JCI Insight
The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction
H Cheng, Yapeng Su, Xiaoli Pan, Yue Xu, Ermei Xie, Jing Du, Daniel G. Chen, Xiaomeng Dai, Raphaël Gottardo, Philip D. Greenberg et al. · 2026 · Nature
Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer
Yun Jin, Pingping Hu, Haihang Sun, Chao Yang, Jianxin Zhai, Yi Wang, Xinyun Chu, Zhiwei Sun, Jia Wang, Jie Sun et al. · 2022 · Molecular Immunology
CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma
Luka de Vos, Tzaitel Maria Carrillo Cano, Romina Zarbl, Niklas Klümper, Damian Johannes Ralser, Alina Franzen, Emmanuelle Herr, Jennis Gabrielpillai, Timo Jakob Vogt, Jörn Dietrich et al. · 2022 · Journal of Immunotherapy
ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control
Tiffany C. Blair, Jason R. Baird, Shelly Bambina, Gwen F. Kramer, Monica Gostissa, Christopher J. Harvey, Michael J. Gough, Marka R. Crittenden · 2022 · Scientific Reports
Focus on T cell exhaustion: new advances in traditional Chinese medicine in infection and cancer
Shenghao Li, Liyuan Hao, Junli Zhang, Jiali Deng, Xiaoyu Hu · 2023 · Chinese Medicine
Immunometabolism: a new dimension in immunotherapy resistance
Chaoyue Xiao, Wei Xiong, Yiting Xu, Jian Peng Zou, Yue Zeng, Junqi Liu, Yurong Peng, Chunhong Hu, Fang Wu · 2023 · Frontiers of Medicine
High HPK1+PD-1+TIM-3+CD8+ T cells infiltration predicts poor prognosis to immunotherapy in NSCLC patients
Jingxin Zhang, Ziyuan Ren, Yun Yu Hu, Shijie Shang, Ruiyang Wang, Jiachun Ma, Zengfu Zhang, Meng Wu, Fei Wang, Jinming Yu et al. · 2023 · International Immunopharmacology
Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity
Batel Sabag, Abhishek Puthenveetil, Moria Levy, Noah Joseph, Tirza Doniger, Orly Yaron, Sarit Karako‐Lampert, Itay Lazar, Fatima Awwad, Shahar Ashkenazi et al. · 2024 · The EMBO Journal
Fate induction in CD8 CAR T cells through asymmetric cell division
Casey S. Lee, Sisi Chen, Corbett T. Berry, Andre R. Kelly, Patrick J. Herman, Sangwook Oh, Roddy S. O’Connor, Aimee S. Payne, Christoph T. Ellebrecht · 2024 · Nature
Exosomes as a Therapeutic Strategy in Cancer: Potential Roles as Drug Carriers and Immune Modulators
Azam Abedi, Mehrdad Moosazadeh Moghaddam, Reza Kachuei, Abbas Ali Imani Fooladi · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition
Melanie Urbanek‐Quaing, Yin-Han Chou, Manoj Kumar Gupta, Katja Steppich, Birgit Bremer, Hagen Schmaus, Katja Deterding, Benjamin Maasoumy, Heiner H. Wedemeyer, Cheng‐Jian Xu et al. · 2024 · Hepatology
Gene Regulatory Network Rewiring in the Immune Cells Associated with Cancer
Pengyong Han, Chandrasekhar Gopalakrishnan, Haiquan Yu, Edwin Wang · 2017 · Genes
The host protecting the tumor from the host — targeting PD‑L1 expressed by host cells
David H. Munn · 2018 · Journal of Clinical Investigation
UTX promotes CD8+ T cell-mediated antiviral defenses but reduces T cell durability
Joseph E. Mitchell, Makayla M. Lund, Josh Starmer, Kai Ge, Terry Magnuson, Karl B. Shpargel, Jason K. Whitmire · 2021 · Cell Reports
“Go”, “No Go,” or “Where to Go”; does microbiota dictate T cell exhaustion, programming, and HIV persistence?
Sudhanshu Shukla, Sangeeta Kumari, Saswat Kumar Bal, Daniela C. Mónaco, Susan Pereira Ribeiro, Rafick‐Pierre Sékaly, Ashish Sharma · 2021 · Current Opinion in HIV and AIDS
Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
Marcus T. T. Roalsø, Øyvind H. Hald, Marina Alexeeva, Kjetil Søreide · 2022 · Cancers
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
David Escors, Ana Bocanegra, Luisa Chocarro, Ester Blanco, Sergio Piñeiro‐Hermida, Maider Garnica, Leticia Fernández, Ruth Vera, Hugo Arasanz, Grazyna T. Kochan · 2022 · International Journal of Molecular Sciences
Cyclophosphamide treatment regulates the balance of functional/exhausted tumor-specific CD8+T cells
Aurélie Hanoteau, Coralie Henin, Dávid Švec, Charlotte Bisilliat Donnet, Sébastien Denanglaire, Didier Colau, Pedro J. Romero, Oberdan Léo, Benoit J. Van den Eynde, Muriel Moser · 2017 · OncoImmunology
Exhausted-like Group 2 Innate Lymphoid Cells in Chronic Allergic Inflammation
Takashi Ebihara, Ichiro Taniuchi · 2019 · Trends in Immunology
Resilience of T cell-intrinsic dysfunction in transplantation tolerance
Michelle L. Miller, Christine M. Mcintosh, Ying Wang, Luqiu Chen, Peter Wang, Yuk Man Lei, Melvin D. Daniels, Elyse A. Watkins, Carolina Mora-Solano, Anita S. Chong et al. · 2019 · Proceedings of the National Academy of Sciences
The Naming of Memory T-Cell Subsets
Stephen C. Jameson · 2020 · Cold Spring Harbor Perspectives in Biology
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit
Kristen E. Pauken, Omar Alhalabi, Sangeeta Goswami, Padmanee Sharma · 2025 · Cancer Cell
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects
Michela Capello, Angelica Sette, Theo S. Plantinga, Craig J. Thalhauser, Vanessa M. Spires, Kristina Nuermberger, Jordan M. Blum, Brandon W. Higgs, Patricia Garrido Castro, Christina Y. Yu et al. · 2025 · Journal for ImmunoTherapy of Cancer
Deciphering the role of histone modifications in memory and exhausted CD8 T cells
Hua Huang, Amy E. Baxter, Zhen Zhang, Charly Ryan Good, Katherine A. Alexander, Zeyu Chen, Paula A. Agudelo Garcia, Parisa Samareh, Sierra M. Collins, Karl M. Glastad et al. · 2025 · Scientific Reports
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma
Yichuan Yuan, Yi Niu, Zhenkun Huang, Yunxing Shi, Lin Zhu, Dinglan Zuo, Chengrui Zhong, Kai Li, Xin‐Yuan Guan, Yunfei Yuan et al. · 2025 · Proceedings of the National Academy of Sciences
Atlas-guided discovery of transcription factors for T cell programming
H. Kay Chung, Cong Liu, Anamika Battu, Alexander N. Jambor, Brandon M. Pratt, Fucong Xie, Brian Riesenberg, Eduardo Casillas, Ming Sun, Elisa Landoni et al. · 2026 · Nature
Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
Salvatore Cortellino, Margherita D’Angelo, Massimiliano Quintiliani, Antonio Giordano · 2024 · Journal of Cellular Physiology
Effect of the hairpin structure of peptide inhibitors on the blockade of PD-1/PD-L1 axis
Kai Wang, Yanhui Song, Yu Su, Yuting Liang, Liping Wang · 2020 · Biochemical and Biophysical Research Communications
Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition?
Tamer Adel Othman, Alex Francisco Herrera, Matthew Genyeh Mei · 2021 · Current Hematologic Malignancy Reports
Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C
Valeria Barili, Andrea Lorenzo Vecchi, Marzia Rossi, Ilaria Montali, Camilla Tiezzi, Amalia Penna, Diletta Laccabue, Gabriele Missale, Paola Fisicaro, Carolina Boni · 2021 · Cells
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
Jessica Waibl Polania, Emily Lerner, Daniel S. Wilkinson, Alexandra M. Hoyt-Miggelbrink, Peter Edward Fecci · 2021 · Frontiers in Immunology
Precision oncology for breast cancer through clinical trials
Aurora Blucher, Gordon Brent Mills, Yiu Huen Tsang · 2021 · Clinical & Experimental Metastasis
Therapeutic potential of targeting LAG-3 in cancer
Diwakar Davar, Ana Carrizosa Anderson, Iván Díaz-Padilla · 2025 · Journal for ImmunoTherapy of Cancer
Bifidobacterium infantis regulates the programmed cell death 1 pathway and immune response in mice with inflammatory bowel disease
Linyan Zhou, Ying Xie, Yan Li · 2022 · World Journal of Gastroenterology
Epigenetic engineering for optimal chimeric antigen receptor T cell therapy
Yusuke Ito, Yuki Kagoya · 2022 · Cancer Science
Strong Basal/Tonic TCR Signals Are Associated with Negative Regulation of Naive CD4+ T Cells
Wendy M. Zinzow-Kramer, Elizabeth Motunrayo Kolawole, Joel Eggert, Brian D. Evavold, Christopher D. Scharer, Byron B. Au‐Yeung · 2022 · ImmunoHorizons
Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
Yanting Zhou, Hongyan Li · 2023 · Frontiers in Neuroscience
Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors
Sang-Hee Lee, Min Jun Ko, Rony Avritscher, Robert J. Lewandowski, Dong‐Hyun Kim · 2024 · ACS Nano
A Copper-Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti-Tumor Immune Responses.
Luoyingzi Xie, Jie Gong, Zhiqiang He, Wei-Nan Zhang, Hao-Yue Wang, Shitao Wu, Xian-Xing Wang, Pi-Jiang Sun, Lei Cai, Zhong-Jun Wu et al. · 2025 · Small
Stability and flexibility in chromatin structure and transcription underlies memory CD8 T-cell differentiation
Hui-Tian Diao, M. Pipkin · 2019 · F1000Research
Prognostic Biomarkers for Melanoma Immunotherapy
Chris Twitty, Laura Ann Huppert, ADIL I. DAUD · 2020 · Current Oncology Reports
Harnessing CD8+ T‐cell exhaustion to treat type 1 diabetes
Chun-Ting J. Kwong, Claudia Selck, Krisna Tahija, Lachlan J McAnaney, Dan V Le, Thomas W. H. Kay, Helen E. Thomas, Balasubramanian Krishnamurthy · 2021 · Immunology and Cell Biology
Muscle Gene Sets: a versatile methodological aid to functional genomics in the neuromuscular field
Apostolos Malatras, Stéphanie Duguez, William John Duddy · 2019 · Skeletal Muscle
Can T cells be too exhausted to fight back?
Stephen J. Turner, Brendan E. Russ · 2016 · Science
Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research
Xiangfei Su, Mi Zhang, Hong Zhu, Jingwen Cai, Zhen Wang, Yuewei Xu, Li Wang, Chen Shen, Ming M. Cai · 2025 · Biological Procedures Online
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma
Kelly M. Mahuron, Osmaan Shahid, Prachi Sao, Clinton Wu, Alexandra M. Haugh, Laura Ann Huppert, Lauren S. Levine, Margaret M. Lowe, Michael Alvarado, Markee Micu et al. · 2025 · Cancer Research
Cholinergic T cells revitalize the tumor immune microenvironment: TIME to ChAT
Chunxing Zheng, Shaofeng Liu, Nastaran Fazel Modares, Michael St. Paul, Tak W. Mak · 2025 · Nature Immunology
Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors
Claire Gallois, Margherita Ambrosini, Sara Lonardi, Emily Linda Alouani, Rosine Guimbaud, Michael James Overman, Frank A. Sinicrope, Thibault Mazard, Marie Decraecker, Javier Ros et al. · 2025 · European Journal of Cancer
Analysis of the three-dimensional genome of exhausted CD8+ T cells reveals a critical role of IRF8 in their differentiation and functions in cancer
Ruifeng Li, Kun Wei, Qinli Sun, Bowen Xie, Peng Wei, Tian Xie, Xinyi Guo, Yongzhen Chen, Bi-Rui Pan, Zixuan Zhao et al. · 2025 · Nature Immunology
Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity
Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo · 2021 · Journal of Histochemistry & Cytochemistry
New epigenetic regulators of T cell exhaustion
Haydn Thomas Kissick, Rafi Ahmed · 2022 · Cancer Cell
Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus
Mingshu Huang, Weixing Chen, Min Wang, Yisheng Huang, Hongyu Liu, Yue Ming, Yuanxin Chen, Zhengming Tang, Bo Jia · 2023 · BioDrugs
Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade
Weihong Tian, Gaofeng Qin, Miaomiao Jia, Wuhao Li, Weili Cai, Hui Wang, Yangjing Zhao, Xuanwen Bao, Wangzhi Wei, Yu Zhang et al. · 2023 · Frontiers in Immunology
Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection
Menghan Su, Ting Ye, Wei Wu, Zheyue Shu, Qi Xia · 2023 · Digestive Diseases
Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives
Sultana Mehbuba Hossain, Carien Carpenter, Michael Roger Eccles · 2024 · International Journal of Molecular Sciences
Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders
Xintong Li, Yuanxin Liu, Jun Gui, Lu Gan, Jianxin Xue · 2024 · Advanced Science
BTN3A1 expressed in cervical cancer cells promotes Vγ9Vδ2 T cells exhaustion through upregulating transcription factors NR4A2/3 downstream of TCR signaling
Jian Liu, Min Wu, Yifan Yang, Xinyu Mei, Liming Wang, Jingyu Wang, Zixuan Wang, Shan He, Hangyu Liu, Han Jiang et al. · 2024 · Cell Communication and Signaling
Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity
Lih‐Yun Hsu, James Todd Rosenbaum, Erik J. Verner, William B. Jones, Craig M. Hill, James W. Janc, Joseph J. Buggy, Rahul D. Pawar, Poorva Ghosh, Dan Li et al. · 2024 · npj Drug Discovery.
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and Survival
Sophia M. Loick, Anne Fröhlich, Jennis Gabrielpillai, Alina Franzen, Timo J. Vogt, Jörn Dietrich, Constanze Wiek, Kathrin Scheckenbach, Sebastian Strieth, Jennifer Landsberg et al. · 2021 · Journal of Immunotherapy
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
Emelie Rådestad, Lars Egevad, Carl Jorns, Jonas Mattsson, Berit Sundberg, Silvia Nava, Bo‐Göran Ericzon, Lars Henningsohn, Victor Levitsky, Michael Uhlin · 2017 · Oncotarget
Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
Artemis Gavriil, Marta Barisa, Emma Halliwell, John Anderson · 2020 · Cancers
An Updated Model for the Epigenetic Regulation of Effector and Memory CD8+ T Cell Differentiation
Tianhao Xu, Renata M. Pereira, Gustavo Martínez · 2021 · The Journal of Immunology
Chronic LCMV Infection Is Fortified with Versatile Tactics to Suppress Host T Cell Immunity and Establish Viral Persistence
Caleb J. Studstill, Bumsuk Hahm · 2021 · Viruses
Polysaccharide Peptide Induced Colorectal Cancer Cells Apoptosis by Down-Regulating EGFR and PD-L1 Expression
Jian Lin, Zhicheng He, Shubai Liu · 2022 · Iranian journal of pharmaceutical research
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state, and its deletion improves checkpoint blockade
Susan McClory, Oishi Bardhan, Kelly Rome, Josephine Ruth Giles, Amy E. Baxter, Lanwei Xu, Phyllis A. Gimotty, Robert B. Faryabi, E. John Wherry, Warren S. Pear et al. · 2023 · Cell Reports
LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy
Jiqi Shan, Jing Wei, Ping Yü, Chunyi Shen, Dong Hun Han, Fengsen Liu, Yaqing Liu, Congcong Li, Yi Zhang · 2023 · OncoImmunology
Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy
Han Zhang, Wenjin Xu, Haitao Zhu, Xuelian Chen, Hsiang‐i Tsai · 2024 · Journal of Cancer
ER-associated degradation adapter Sel1L is required for CD8+ T cell function and memory formation following acute viral infection
Luis O. Correa, Shayna E. Jankowski, Hanna S. Hong, Nicholas D Armas, Aditi I Vijendra, Mack B. Reynolds, Garrett M. Fogo, Dominik Awad, Alexander T. Dils, Kantaro A Inoki et al. · 2024 · Cell Reports
Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice
Hailyn V. Nielsen, Letitia Yang, James L. Mueller, Alexander J. Ritter, Ryosuke Hiwa, Irina Proekt, Elze Rackaityte, Dominik A. Aylard, Mansi Gupta, Christopher D. Scharer et al. · 2025 · Nature Communications